We were delighted to take part in the 8th Swiss-Chinese Life Sciences Forum, an inspiring event bringing together biotech, pharma, and investment leaders committed to shaping the future of healthcare innovation between Switzerland and China.

The forum featured dynamic discussions on R&D trends, regulatory harmonization, and cross-border investment strategies. It reinforced the importance of international collaboration in driving breakthroughs across the life sciences ecosystem.

Our representatives, Nathalie Schober-Ladani, Head Commercial, Jane Müller, Head Legal and Joanna Hanley, Head Quality Assurance, left with invaluable insights that will strengthen our ability to help clients scale globally, adapt to evolving markets, and stay ahead in an ever-shifting regulatory landscape.